Early detection of patients at risk for sepsis
Part of Infections clinical trials.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected or confirmed infection.
- You have a high early warning score that suggests you may be getting worse quickly.
- You are 18 years old or older.
- You have not had a recent traumatic injury or major bleeding in your stomach or lungs.
- You are not too frail (Rockwood score less than 6) and you have not already refused intensive care treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is building a tool to predict sepsis, a life-threatening response to infection, in intensive care patients. It may help doctors act faster to prevent complications.
This study looks at whether automatically flagging a sepsis risk score in the electronic health record and having a care team respond with structured steps helps treat sepsis earlier. If you qualify, everything is done through your usual care — you won't have extra visits or be contacted by the research team.
This trial tests a special way to monitor tiny blood vessels (microcirculation) in patients with sepsis. The goal is to see if early treatment based on these readings can help improve recovery.
This trial tests whether a quick genetic test can help doctors choose the right treatment for patients with a suspected severe infection (sepsis) more quickly. The goal is to improve recovery by personalizing care based on your body's response.
This study tests two new blood tests to see if they can help doctors find sepsis earlier in the emergency department. Sepsis is a serious condition where the body overreacts to an infection, and finding it quickly could lead to faster treatment and better outcomes.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.